38 results on '"Oueslati, Saoussen"'
Search Results
2. Multidrug-resistant Enterobacterales responsible for septicaemia in a neonatal intensive care unit in Morocco
- Author
-
Perez-Palacios, Patricia, Girlich, Delphine, Soraa, Nabila, Lamrani, Asmae, Maoulainine, Fadl Mrabih Rabo, Bennaoui, Fatiha, Amri, Hasna, EL IDRISSI, Nadia Slitine, Bouskraoui, Mohammed, Birer, Aurélien, Jousset, Agnes B., Oueslati, Saoussen, Raymond, Josette, and Naas, Thierry
- Published
- 2023
- Full Text
- View/download PDF
3. Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation
- Author
-
Mendels, David-A., Dortet, Laurent, Emeraud, Cécile, Oueslati, Saoussen, Girlich, Delphine, Ronat, Jean-Baptiste, Bernabeu, Sandrine, Bahi, Silvestre, Atkinson, Gary J. H., and Naas, Thierry
- Published
- 2021
4. Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181.
- Author
-
Gonzalez, Camille, Oueslati, Saoussen, Rima, Mariam, Nermont, Réva, Dortet, Laurent, Hopkins, Katie L., Iorga, Bogdan I., Bonnin, Rémy A., and Naas, Thierry
- Subjects
ESCHERICHIA coli ,DRUG resistance in bacteria ,CARBAPENEMASE ,IMIPENEM ,CARBAPENEMS - Abstract
OXA-244, an R214G variant of OXA-48, is silently spreading worldwide likely because of difficulties in detection using classical screening media. Here, we characterized two clinical isolates of Escherichia coli and Citrobacter youngae that displayed reduced susceptibility to carbapenems but were lacking significant carbapenemase activity as revealed by negative Carba NP test results. However, positive test results were seen for OXA-48-like enzymes by lateral flow immunoassays. WGS revealed the presence of a blaOXA-181-like gene that codes for OXA-484, an R214G variant of OXA-181. BlaOXA-484 gene was located on a 58.4-kb IncP1-like plasmid (pN-OXA-484), that upon transfer into E. coli HB4 with impaired permeability, conferred carbapenem and temocillin resistance (MICs > 32 mg/L). E. coli TOP10 (pTOPO-OXA-484) revealed reduced MICs in most substrates as compared to E. coli TOP10 (pTOPO-OXA-181), especially for imipenem (0.25 mg/L versus 0.75 mg/L) and temocillin (16 mg/L versus 1028 mg/L). Catalytic efficiencies of OXA-484 were reduced as compared to OXA-181 for most ß-lactams including imipenem and temocillin with 27.5- and 21.7-fold reduction, respectively. Molecular modeling confirmed that the salt bridges between R214, D159, and the R1 substituent's carboxylate group of temocillin were not possible with G214 in OXA-484, explaining the reduced affinity for temocillin. In addition, changes in active site's water network may explain the decrease in hydrolysis rate of carbapenems. OXA-484 has weak imipenem and temocillin hydrolytic activities, which may lead to silent spread due to underdetection using selective screening media or biochemical imipenem hydrolysis confirmatory tests. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
- Author
-
Daaboul, Dina, Osman, Marwan, Kassem, Issmat I, Yassine, Iman, Girlich, Delphine, Proust, Alexis, Mounir, Chemsi, Zerouali, Khalid, Raymond, Josette, Naas, Thierry, and Oueslati, Saoussen
- Subjects
NEONATAL sepsis ,PSEUDOMONAS aeruginosa ,NEONATAL intensive care units ,CARBAPENEM-resistant bacteria ,WHOLE genome sequencing ,ACINETOBACTER infections ,PSEUDOMONAS aeruginosa infections - Abstract
Background Carbapenem-resistant Pseudomonas aeruginosa are being increasingly described worldwide. Here, we investigated the molecular mechanisms underlying carbapenem resistance in an extremely drug-resistant P. aeruginosa isolate from a neonatal intensive care unit in Morocco. Materials and methods P. aeruginosa strain O82J1 was identified using MALDI-TOF-MS. Carba NP, immunochromatographic assay NG Carba5 and antimicrobial susceptibility testing using disc diffusion and microbroth were performed. Whole-genome sequencing using the Illumina and MinION technologies and different software packages available at the Center of Genomic Epidemiology were used to predict the resistome, sequence type and plasmid types. Results P. aeruginosa O82J1 co-expressed two metallo-β-lactamases, bla
NDM-1 and blaVIM-2 , and was susceptible to colistin and apramycin only. It belonged to ST773 that is frequently reported worldwide as a high-risk P. aeruginosa clone. The blaVIM-2 gene was integron-borne on a IncP-2 465-kb plasmid, whereas the blaNDM-1 gene was chromosomally encoded and embedded in an integrative conjugative element, probably at the origin of its acquisition. A total of 23 antimicrobial resistance genes were detected including a blaPER-1 ESBL gene, and an 16S-rRNA methyltransferase gene rmtB. Conclusions The isolation of XDR P. aeruginosa isolates expressing several carbapenemases in a neonatal intensive care unit is of great concern due to the reduced treatment options, relying only on colistin, but not recommended in neonates, and apramycin, not yet approved for human therapy. Concerns were further elevated due to the resistance to cefiderocol and ATM/AVI, two novel and last-resort antibiotics recommended to treat infections caused by Gram-negative bacteria, particularly XDR P. aeruginosa in adults. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
- Author
-
Romero, Eugénie, Oueslati, Saoussen, Benchekroun, Mohamed, D’Hollander, Agathe C.A., Ventre, Sandrine, Vijayakumar, Kamsana, Minard, Corinne, Exilie, Cynthia, Tlili, Linda, Retailleau, Pascal, Zavala, Agustin, Elisée, Eddy, Selwa, Edithe, Nguyen, Laetitia A., Pruvost, Alain, Naas, Thierry, Iorga, Bogdan I., Dodd, Robert H., and Cariou, Kevin
- Published
- 2021
- Full Text
- View/download PDF
7. Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci.
- Author
-
Philip, Axel, Oueslati, Saoussen, Villa, Francesco, Pannetier, Christophe, Cattoir, Vincent, Duranteau, Jacques, Figueiredo, Samy, and Naas, Thierry
- Subjects
- *
ENTEROCOCCUS , *GENES , *TURNAROUND time , *MEDICAL microbiology , *MEDICAL screening - Abstract
Background VRE are increasingly described worldwide. Screening of hospitalized patients at risk for VRE carriage is mandatory to control their dissemination. Here, we have developed the Bfast [VRE Panel] PCR kit, a rapid and reliable quantitative PCR assay for detection of vanA , vanB , vanD and vanM genes, from solid and liquid cultures adaptable to classical and ultrafast real-time PCR platforms. Methods Validation was carried out on 133 well characterized bacterial strains, including 108 enterococci of which 64 were VRE. Analytical performances were determined on the CFX96 Touch (Bio-Rad) and Chronos Dx (BforCure), an ultrafast qPCR machine. Widely used culture plates and broths for enterococci selection/growth were tested. Results All targeted van alleles (A, B, D and M) were correctly detected without cross-reactivity with other van genes (C, E, G, L and N) and no interference with the different routinely used culture media. A specificity and sensitivity of 100% and 99.7%, respectively, were determined, with limits of detection ranging from 21 to 238 cfu/reaction depending on the targets. The Bfast [VRE Panel] PCR kit worked equally well on the CFX and Chronos Dx platforms, with differences in multiplexing capacities (five and four optical channels, respectively) and in turnaround time (45 and 16 minutes, respectively). Conclusions The Bfast [VRE Panel] PCR kit is robust, easy to use, rapid and easily implementable in clinical microbiology laboratories for ultra-rapid confirmation of the four main acquired van genes. Its features, especially on Chronos Dx, seem to be unmatched compared to other tools for screening of VRE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria.
- Author
-
Yousfi, Chahrazed, Oueslati, Saoussen, Daaboul, Dina, Girlich, Delphine, Proust, Alexis, Bentchouala, Chafia, and Naas, Thierry
- Subjects
ABSCESSES ,ESCHERICHIA coli ,SLAUGHTERING ,ANTIBIOTICS ,SHEEP ,MANNHEIMIA haemolytica - Abstract
Abscesses represent the most prominent emerging problem in the red meat industry, leading to great economic constraints and public health hazards. Data on etiological agents present in these purulent lesions in Algeria are very scarce. The aim of this study was to identify the bacteria responsible for these abscesses and to determine their antibiotic susceptibility profiles. A total of 123 samples of abscesses from 100 slaughtered sheep and 23 slaughtered cattle were cultured in several media. A total of 114 bacterial isolates were cultured from 103 abscesses. Bacteria were identified using MALDI–TOF, and antibiotic susceptibility was determined by the disk diffusion method on Mueller–Hinton agar. A total of 73.6% (n = 84) corresponded to Enterobacterales, of which four were multidrug-resistant (MDR). These isolates, together with Staphylococcus aureus, coagulase negative Staphylococci, and seven randomly chosen susceptible Escherichia coli isolates, were further characterized using WGS. Resistome analysis of the four MDR Enterobacterales isolates revealed the presence of OXA-48 carbapenemase in two Klebsiella pneumoniae ST985 and one E. coli ST10 isolates and a CTX-M-15 ESBL in one E. coli isolate ST1706. Two coagulase-negative Staphylococci isolates were found to carry the mecA gene. WGS showed the presence of different resistance genes and virulence genes. Our study revealed 5% of MDR Enterobacterales (including ESBLs and carbapenemases) identified from abscesses, thus urging the need for abscess monitoring in slaughterhouses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Emergence of blaNDM-5-harbouring Escherichia coli ST617 in refugee and host communities and their environment.
- Author
-
Daaboul, Dina, Kassem, Issmat I, Omari, Khaled El, Hamze, Monzer, Daboussi, Fouad, Oueslati, Saoussen, Naas, Thierry, and Osman, Marwan
- Subjects
KLEBSIELLA pneumoniae ,ESCHERICHIA coli ,MOBILE genetic elements ,REFUGEES ,WHOLE genome sequencing - Abstract
This article discusses a study on antimicrobial resistance (AMR) in Lebanon, specifically focusing on the presence of the blaNDM-5 gene in E. coli isolates. The study found that blaNDM-5-harbouring E. coli ST617 was present in Syrian refugees, their animals, and the camp environment, posing a health risk to both the refugees and the hosting community. The study emphasizes the importance of integrated surveillance programs and One Health studies to address AMR in vulnerable populations and highlights the role of war, mass migration, and displacement in the spread of AMR. Funding for the study was provided by various organizations, and ethical considerations were taken into account. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
10. Emergence of NDM-1, VIM-4 and CTX-M-15-co-harbouring Enterobacter xiangfangensis in a bloodstream infection.
- Author
-
Daaboul, Dina, Kassem, Issmat I, Yassine, Iman, Hamze, Monzer, Dabboussi, Fouad, Girlich, Delphine, Oueslati, Saoussen, Naas, Thierry, and Osman, Marwan
- Subjects
CEFTAZIDIME ,ENTEROBACTER ,COLISTIN ,WHOLE genome sequencing ,ESCHERICHIA coli ,ANTI-infective agents ,ENTEROBACTER cloacae - Abstract
This article discusses the emergence of a multidrug-resistant strain of Enterobacter xiangfangensis (Exn692) in a patient with COVID-19 and diabetes in Lebanon. The strain showed resistance to 37 antibiotics from different classes and carried genes that encoded resistance to these antibiotics. However, it was susceptible to a few antibiotics. The study emphasizes the challenges in treating infections caused by multidrug-resistant bacteria and the importance of effective antimicrobial stewardship. It also highlights the need for monitoring the evolution of Enterobacter xiangfangensis and developing accurate identification tools to understand its epidemiology, pathogenesis, and antibiotic resistance properties. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
11. The emergence of carbapenemase-producing Enterobacterales in hospitals: a major challenge for a debilitated healthcare system in Lebanon.
- Author
-
Daaboul, Dina, Oueslati, Saoussen, Rima, Mariam, Kassem, Issmat I., Mallat, Hassan, Birer, Aurélien, Girlich, Delphine, Hamze, Monzer, Dabboussi, Fouad, Osman, Marwan, and Naas, Thierry
- Published
- 2023
- Full Text
- View/download PDF
12. Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9.
- Author
-
Gaillot, Susie, Oueslati, Saoussen, Vuillemenot, Jean-Baptiste, Bour, Maxime, Iorga, Bogdan I., Triponney, Pauline, Plésiat, Patrick, Bonnin, Rémy A., Naas, Thierry, Jeannot, Katy, and Potron, Anaïs
- Subjects
ACINETOBACTER baumannii ,ESCHERICHIA coli ,WHOLE genome sequencing ,IONIC interactions ,MOLECULAR docking - Abstract
Here, we characterized the first French NDM-9-producing Acinetobacter baumannii isolate. A. baumannii 13A297, which belonged to the ST
Pas 25 (international clone IC7), was highly resistant to β-lactams including cefiderocol (MIC >32 mg/L). Whole genome sequencing (WGS) using both Illumina and Oxford Nanopore technologies revealed a 166-kb non-conjugative plasmid harboring a blaNDM-9 gene embedded in a Tn125 composite transposon. Complementation of E. coli DH5α and A. baumannii CIP70.10 strains with the pABEC plasmid carrying the blaNDM-1 or blaNDM-9 gene, respectively, resulted in a significant increase in cefiderocol MIC values (16 to >256-fold), particularly in the NDM-9 transformants. Interestingly, steady-state kinetic parameters, measured using purified NDM-1 and NDM-9 (Glu152Lys) enzymes, revealed that the affinity for cefiderocol was 3-fold higher for NDM-9 (Km = 53 μM) than for NDM-1 (Km = 161 μM), leading to a 2-fold increase in catalytic efficiency for NDM-9 (0.13 and 0.069 μM−1 . s−1 , for NDM-9 and NDM-1, respectively). Finally, we showed by molecular docking experiments that the residue 152 of NDM-like enzymes plays a key role in cefiderocol binding and resistance, by allowing a strong ionic interaction between the Lys152 residue of NDM-9 with both the Asp223 residue of NDM-9 and the carboxylate group of the R1 substituent of cefiderocol. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
13. In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates.
- Author
-
Rima, Mariam, Pfennigwerth, Niels, Cremanns, Martina, Cirnski, Katarina, Oueslati, Saoussen, Gatermann, Sören G., d'Amélio, Nicola, Herrmann, Jennifer, Müller, Rolf, and Naas, Thierry
- Subjects
CARBAPENEMS ,ACINETOBACTER baumannii ,GRAM-positive bacteria ,ANTIBIOTICS assay ,GRAM-negative bacteria ,KLEBSIELLA pneumoniae ,DRUG resistance in bacteria - Abstract
The development of novel antibiotics is mandatory to curb the growing antibiotic resistance problem resulting in difficult-to-treat bacterial infections. Here, we have determined the spectrum of activity of cystobactamids and chelocardins, two novel and promising classes of molecules with different modes of action. A panel of 297 clinically relevant Gram-negative and Gram-positive isolates with different antibiotic susceptibility profiles, going from wild type to multi- or even extremely drug resistant (MDR, XDR) and including carbapenem-resistant isolates, were tested using broth microdilution assays to determine the minimal inhibitory concentrations (MICs), MIC50s and MIC90s of two cystobactamids derivatives (CN-861-2 and CN-DM-861) and two chelocardin derivatives (CHD and CDCHD). Cystobactamids revealed potent activities on the majority of tested Enterobacterales (MIC50s ranging from 0.25 to 4 µg/mL), except for Klebsiella pneumoniae isolates (MIC50s is 128 µg/mL). Pseudomonas aeruginosa and Acinetobacter baumannii showed slightly higher MIC50s (4 µg/mL and 8 µg/mL, respectively) for cystobactamids. Chelocardins inhibited the growth of Enterobacterales and Stenotrophomas maltophilia at low to moderate MICs (0.25–16 µg/mL) and the chemically modified CDCHD was active at lower MICs. A. baumannii and P. aeruginosa were less susceptible to these molecules with MICs ranging from 0.5 to 32 µg/mL. These molecules show also interesting in vitro efficacies on clinically relevant Gram-positive bacteria with MICs of 0.125–8 µg/mL for cystobactamids and 0.5–8 µg/mL for chelocardins. Taken together, the cystobactamid CN-DM-861 and chelocardin CDCHD showed interesting antibiotic activities on MDR or XDR bacteria, without cross-resistance to clinically relevant antibiotics such as carbapenems, fluoroquinolones, and colistin. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria.
- Author
-
Gonzalez, Camille, Volland, Hervé, Oueslati, Saoussen, Niol, Léa, Legrand, Camille, Francius, Laura, Chalin, Arnaud, Vogel, Anaïs, Simon, Stéphanie, and Naas, Thierry
- Subjects
GRAM-negative bacteria ,MEDICAL microbiology ,CARBAPENEMS ,AGAR plates ,DETECTION limit ,CARBAPENEMASE ,AGAR - Abstract
Background As carbapenemase-producing Enterobacterales are increasingly reported worldwide, their rapid detection is crucial to reduce their spread and prevent infections and outbreaks. Lateral flow immunoassays (LFIAs) have become major tools for the detection of carbapenemases. However, as for most commercially available assays, only the five main carbapenemases are targeted. Objectives Here, we have developed and evaluated an LFIA prototype for the rapid and reliable detection of the increasingly identified GES-type β-lactamases. Methods The GES LFIA was validated on 103 well-characterized Gram-negative isolates expressing various β-lactamases grown on Mueller–Hinton (MH) agar, chromogenic, and chromogenic/selective media. Results The limit of detection of the assay was 10
6 cfu per test with bacteria grown on MH agar plates. GES LFIA accurately detected GES-type β-lactamases irrespective of the culture media and the bacterial host. The GES LFIA was not able to distinguish between GES-ESBLs and GES-carbapenemases. Because GES enzymes are still rare, their detection as an ESBL or a carbapenemase remains important, especially because extensive use of carbapenems to treat ESBL infections may select for GES variants capable of hydrolysing carbapenems. Conclusions The GES LFIA is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratory for the confirmation of GES-type β-lactamases. Combining it with immunochromatographic assays targeting the five main carbapenemases (KPC, NDM, VIM, IMP and OXA-48) would improve the overall sensitivity for the most frequently encountered carbapenemases and ESBLs, especially in non-fermenters. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
15. Evaluation of InTray Cassettes Directly from Blood Cultures for the Diagnosis of Sepsis in Clinical Bacteriology Laboratories as an Alternative to Classic Culture Media.
- Author
-
Natale, Alessandra, Oueslati, Saoussen, Rochard, Alice, Ombelet, Sien, Lopez-Baez, Daniel, Hardy, Liselotte, Cunningham, Jane, Franquesa, Céline, Vandenberg, Olivier, Ronat, Jean-Baptiste, and Naas, Thierry
- Subjects
- *
NEONATAL sepsis , *PATHOLOGICAL laboratories , *SEPSIS , *BACTERIAL diseases , *DIAGNOSIS , *MEDICAL screening - Abstract
Culture media is fundamental in clinical bacteriology for the detection and isolation of bacterial pathogens. However, in-house media preparation could be challenging in low-resource settings. InTray® cassettes (Biomed Diagnostics) could be a valid alternative as they are compact, ready-to-use media preparations. In this study, we evaluate the use of two InTray media as a subculture alternative for the diagnosis of bloodstream infections: the InTray® Müller-Hinton (MH) chocolate and the InTray® Colorex™ Screen. The InTray MH chocolate was evaluated in 2 steps: firstly, using simulated positive blood cultures (reference evaluation study), and secondly, using positive blood cultures from a routine clinical laboratory (clinical evaluation study). The Colorex Screen was tested using simulated poly-microbial blood cultures. The sensitivity and specificity of the InTray MH chocolate were respectively 99.2% and 90% in the reference evaluation study and 97.1% and 88.2% in the clinical evaluation study. The time to detection (TTD) was ≤20 h in most positive blood cultures (99.8% and 97% in the two studies, respectively). The InTray® MH Chocolate agar showed good performance when used directly from clinical blood cultures for single bacterial infections. However, mixed flora is more challenging to interpret on this media than on Colorex™ Screen, even for an experienced microbiologist. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Clinical Added Value of SARS-CoV-2 Antigen Detection in Blood Samples.
- Author
-
Oueslati, Saoussen, Manai Bouokazi, Melek, Ramdhani, Ikrame, Escaut, Lélia, Pham, Tài, Ouzani, Souad, Anguel, Nadia, Bulifon, Sophie, Vauloup-Fellous, Christelle, Coilly, Audrey, Legros, Laurence, Guichardon, Magali, Fortineau, Nicolas, Dortet, Laurent, Roque-Afonso, Anne-Marie, and Naas, Thierry
- Subjects
- *
SARS-CoV-2 , *BLOOD sampling , *ANTIGENS , *COVID-19 , *DIAGNOSIS methods - Abstract
This study evaluated the performances of immunoassays (LFIA and ELISA) designed for SARS-CoV-2 Antigen (Ag)-detection in nasopharyngeal (NP) and serum samples in comparison to RT-PCR. NP samples from patients with respiratory symptoms (183 RT-PCR-positive and 74 RT-PCR-negative samples) were collected from March to April and November to December 2020. Seroconversion and antigen dynamics were assessed by symptom onset and day of RT-PCR diagnosis. Serum samples from 87 COVID-19 patients were used to investigate the added value of Ag quantification, at diagnosis and during follow-up. The sensitivity of COVID-VIRO-LFIA on samples with Ct ≤ 33, considered as the contagious threshold, was 86% on NPs (CI 95%: 79–90.5) and 76% on serum samples (CI 95%: 59.4–88), with a specificity of 100%. Serum N-Ag was detected during active infection as early as day two from symptom onset, with a diagnostic sensitivity of 81.5%. Within one week of symptom onset, diagnostic sensitivity and specificity reached 90.9% (95% CI, 85.1%–94.6%) and 98.3% (95% CI, 91.1%–99.9%), respectively. Serum N-Ag concentration closely correlated with disease severity. Longitudinal analysis revealed the simultaneous increase of antibodies and decrease of N-Ag. Sensitivities of COVID-VIRO-LFIA and COV-QUANTO-ELISA tests on NP and serum samples were close to 80%. They are suitable COVID-19-laboratory diagnostic tests, particularly when blood samples are available, thus reducing the requirement for NP sampling, and subsequent PCR analysis. ELISA titers may help to identify patients at risk of poor outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.
- Author
-
Oueslati, Saoussen, Bogaerts, Pierre, Dortet, Laurent, Bernabeu, Sandrine, Ben Lakhal, Hend, Longshaw, Christopher, Glupczynski, Youri, and Naas, Thierry
- Subjects
GRAM-negative bacteria ,BURKHOLDERIA cepacia ,STENOTROPHOMONAS maltophilia ,ACINETOBACTER baumannii ,COMPARATOR circuits - Abstract
Infections with carbapenem-resistant (CR) Gram-negative (GN) pathogens have increased in many countries worldwide, leaving only few therapeutic options. Cefiderocol (CFDC) is approved in Europe for the treatment of aerobic GN infections in adults with limited treatment options. This study evaluated the in vitro activity of cefiderocol and comparators against multidrug-resistant (MDR) bacteria including meropenem-resistant (MR) or pandrug-resistant (PR) GN clinical isolates from France and Belgium. The minimum inhibitory concentrations (MICs) of CFDC were determined by broth microdilution, using iron-depleted cation-adjusted Mueller–Hinton broth, and were compared to those of 10 last-line antibiotics. The MICs were interpreted according to EUCAST and CLSI breakpoints, and in the absence of species-specific breakpoints, non-species-related pharmacokinetic/pharmacodynamic breakpoints were used. Among the 476 isolates tested, 322 were carbapenemase producers (CP), 58 non-CP-CRs, 52 intrinsically CR, 41 expanded-spectrum cephalosporin resistant and 5 were multi-susceptible. Susceptibility to CFDC was high using EUCAST breakpoints 81%, 99% and 84%, and was even higher using CLSI breakpoints to 93%, 100% and 88% for Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii, respectively. Susceptibility to cefiderocol using non-species-related breakpoints for Stenotrophomonas maltophilia, Achromobacter xylosoxydans and Burkholderia cepacia, was 100%, 100% and 92.3%, respectively. The susceptibility rates were lower with the NDM producers, with values of 48% and 30% using EUCAST breakpoints and 81% and 50% using CLSI breakpoints for Enterobacterales and Acinetobacter spp, respectively. CFDC demonstrated high in vitro susceptibility rates against a wide range of MDR GN pathogens, including MR and PR isolates. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon.
- Author
-
Rima, Mariam, Oueslati, Saoussen, Dabos, Laura, Daaboul, Dina, Mallat, Hassan, Bou Raad, Elie, Achkar, Marcel, Mawlawi, Osman, Bernabeu, Sandrine, Bonnin, Rémy A., Girlich, Delphine, Osman, Marwan, Hamze, Monzer, and Naas, Thierry
- Subjects
GRAM-negative bacteria ,HOSPITALS ,KLEBSIELLA pneumoniae ,PSEUDOMONAS aeruginosa ,ACINETOBACTER ,MEDICAL centers - Abstract
Carbapenem resistance (CR) is an emerging health issue. Epidemiological surveys on carbapenem-resistant Gram-negative bacilli (CR-GNB) in Lebanon remain scarce. In this study, we determined the prevalence of CR-GNB isolated between 2015 to 2019 in three hospitals in northern Lebanon: 311 CR-Enterobacterales (out of 11210; 2.8%), 155 CR-Pseudomonas (out of 1034; 15%) and 106 CR- Acinetobacter (out of 184; 57.6%) were identified. CR mechanisms were determined for 146 randomly chosen isolates: the Carba NP test revealed an enzymatic resistance to carbapenems in 109 isolates (out of 146, 74.7%). Produced carbapenemases were evaluated by the NG-Test Carba5, NG-Test OXA-23 immunochromatographic assays and PCR. Carbapenemase-producing (CP) Enterobacterales expressed bla
OXA-48 -like, blaNDM -like and blaVIM -like genes and CP-Pseudomonas expressed blaIMP -like and blaVIM -like genes, whereas CP-Acinetobacter expressed blaOXA-23 -like genes. The NG-Test Carba5 results were confirmed by PCR sequencing and revealed several variants, such as NDM-19, VIM-62 and OXA-162, never described so far in Lebanon. Isolates with discordant results were sequenced by WGS and highlighted novel variants of the natural oxacillinases of Pseudomonas aeruginosa: blaOXA-50 -like genes. Their role in carbapenem resistance should be further studied. Overall, our findings highlight an alarming situation and encourage health care centers to establish performant registration systems that could help in limiting resistance spread. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
19. Heterogeneous hydrolytic features for OXA-48-like β-lactamases
- Author
-
Oueslati, Saoussen, Nordmann, Patrice, and Poirel, Laurent
- Published
- 2015
- Full Text
- View/download PDF
20. Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes.
- Author
-
Gonzalez, Camille, Oueslati, Saoussen, Biez, Laura, Dortet, Laurent, and Naas, Thierry
- Subjects
- *
ACINETOBACTER baumannii , *MULTIDRUG resistance in bacteria , *BACTERIAL DNA , *NUCLEIC acids , *BETA lactamases , *FLUORESCENT probes , *NUCLEIC acid isolation methods - Abstract
Early detection of multidrug resistant bacteria is of paramount importance for implementing appropriate infection control strategies and proper antibacterial therapies. We have evaluated a novel real-time PCR assay using fluorescent probes and 3base® technology, the EasyScreenTM ESBL/CPO Detection Kit (Genetic Signatures, Newtown, Australia), for the detection of 15 β-lactamase genes (blaVIM, blaNDM, blaIMP, blaOXA-48, blaKPC, blaOXA-23, blaOXA-51, blaSME,blaIMI, blaGES,blaTEM,blaSHV, blaCTX-M,blaCMY, blaDHA) and colistin resistance mcr-1 gene from 341 bacterial isolates (219 Enterobacterales, 66 P. aeruginosa and 56 A. baumannii) that were grown on Mueller–Hinton (MH) agar plates. One colony was suspended in provided extraction buffer, which lyses and converts the nucleic acids into a 3base®-DNA form (cytosines are converted into uracil, and subsequently thymine during PCR). The converted bacterial DNA is then added to the 6 PCR mixes, with primers for three targets plus one internal control. The EasyScreenTM ESBL/CPO Detection Kit was able to detect the 5-major (NDM, VIM, IMP, KPC, OXA-48) and 2-minor (IMI, Sme) carbapenemases and their variants irrespective of the species expressing them with nearly 100% sensitivity and specificity. With cephalosporinases CMY (82% of sensitivity) and DHA (87% of sensitivity) detection of chromosomally encoded variants was less efficient. Similarly, the chromosomally encoded OXA-51 variants were not consistently detected in A. baumannii. Despite being capable of efficiently detecting blaCTX-M-, blaTEM-, blaSHV- and blaGES-like genes, the EasyScreen™ ESBL/CPO Detection Kit was not able to distinguish between penicillinases and ESBL-variants of TEM and SHV and between GES-ESBLs and GES-carbapenemases. As GES enzymes are still rare, their detection as an ESBL or a carbapenemase remains important. Detection of mcr-1 was efficient, but none of the other mcr-alleles were detected in the 341 bacterial isolates tested. The EasyScreenTM ESBL/CPO Detection Kit is adapted for the detection of the most prevalent carbapenemases encountered in Gram-negatives isolated worldwide. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Validation of Three MicroScan ® Antimicrobial Susceptibility Testing Plates Designed for Low-Resource Settings.
- Author
-
Ronat, Jean-Baptiste, Oueslati, Saoussen, Natale, Alessandra, Kesteman, Thomas, Elamin, Wael, Langendorf, Céline, Hardy, Liselotte, Vandenberg, Olivier, and Naas, Thierry
- Subjects
- *
MICROBIAL sensitivity tests , *GRAM-negative bacteria , *TEST design , *STAPHYLOCOCCUS , *ANTIBIOTICS - Abstract
Easy and robust antimicrobial susceptibility testing (AST) methods are essential in clinical bacteriology laboratories (CBL) in low-resource settings (LRS). We evaluated the Beckman Coulter MicroScan lyophilized broth microdilution panel designed to support Médecins Sans Frontières (MSF) CBL activity in difficult settings, in particular with the Mini-Lab. We evaluated the custom-designed MSF MicroScan Gram-pos microplate (MICPOS1) for Staphylococcus and Enterococcus species, MSF MicroScan Gram-neg microplate (MICNEG1) for Gram-negative bacilli, and MSF MicroScan Fastidious microplate (MICFAST1) for Streptococci and Haemophilus species using 387 isolates from routine CBLs from LRS against the reference methods. Results showed that, for all selected antibiotics on the three panels, the proportion of the category agreement was above 90% and the proportion of major and very major errors was below 3%, as per ISO standards. The use of the Prompt inoculation system was found to increase the MIC and the major error rate for some antibiotics when testing Staphylococci. The readability of the manufacturer's user manual was considered challenging for low-skilled staff. The inoculations and readings of the panels were estimated as easy to use. In conclusion, the three MSF MicroScan MIC panels performed well against clinical isolates from LRS and provided a convenient, robust, and standardized AST method for use in CBL in LRS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015.
- Author
-
Patiño-Navarrete, Rafael, Rosinski-Chupin, Isabelle, Cabanel, Nicolas, Zongo, Pengdbamba Dieudonné, Héry, Mélanie, Oueslati, Saoussen, Girlich, Delphine, Dortet, Laurent, Bonnin, Rémy A., Naas, Thierry, and Glaser, Philippe
- Published
- 2022
- Full Text
- View/download PDF
23. Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11 , 482.
- Author
-
Muntean, Andrei-Alexandru, Muntean, Madalina-Maria, Oueslati, Saoussen, Bonnin, Remy, Naas, Thierry, and Popa, Mircea Ioan
- Subjects
ACINETOBACTER baumannii ,PATHOGENIC microorganisms ,GRAM-negative bacteria ,CARBAPENEMASE ,BETA lactamases ,MEROPENEM - Abstract
While there are numerous variants of CIM that have been proposed [[1]], the "rCIM-A" name has already been published almost a year ago to define a rapid CIM (rCIM) protocol that optimizes results for chromosomal cephalosporinase (AmpC) hyper-producing Enterobacterales [[3]]. The Carbapenem Inactivation Method became "rapid" with the work by Muntean et al. [[6]] with final test results in less than 3 h, a time-to-result similar to those of other rapid CPE confirmation methods (colorimetric, spectrometry, etc.), thus changing the paradigm of CIM testing. As stated by Gauthier et al. interpretation of growth of I E. coli i ATCC 25922 on Mueller-Hinton agar in relation to the antibiotic is not always interpretable at 6 h [[5]]. References 1 Mitteregger D., Wessely J., Barisi'c I., Bedeni'c B., Kosak D., Kundi M. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter Baumannii Group with Shortened Time-to-Result: RCIM-A. Pathogens. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
24. Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
- Author
-
Muntean, Mădălina Maria, Muntean, Andrei-Alexandru, Guerin, François, Cattoir, Vincent, Creton, Elodie, Cotellon, Garance, Oueslati, Saoussen, Popa, Mircea Ioan, Girlich, Delphine, Iorga, Bogdan I., Bonnin, Rémy A., and Naas, Thierry
- Subjects
SENSITIVITY & specificity (Statistics) ,CARBAPENEMS ,ANTIBIOTICS - Abstract
Objectives: Detection of carbapenemase-producing Enterobacterales (CPEs) is sometimes difficult with AmpC-hyperproducing Enterobacterales (AHEs), as they may falsely be classified as CPEs. Here, we present a rapid Carbapenem Inactivation Method (rCIM) optimized for AmpC producers (rCIM-A) that allows rapid and easy discrimination between AHEs and CPEs.Methods: Enterobacterales (n = 249), including natural AmpC producers, AHEs, CPEs and non-carbapenemase-producing carbapenem-resistant control strains were evaluated, using Carba NP, rCIM and rCIM-A. The rCIM-A differs from the rCIM by the addition of cloxacillin (400 μg/mL) to the initial antibiotic incubation step.Results: The rCIM-A yielded a sensitivity and specificity of 84.26% (95% CI: 76.00%-90.55%) and 99.29% (95% CI: 96.11%-99.98%), respectively, while those of the rCIM were 86.11% (95% CI: 78.13%-92.01%) and 80.85% (95% CI: 73.38%-86.99%), respectively; those of Carba NP were lower at 84.04% (95% CI: 75.05%-90.78%) and 91.37% (95% CI: 85.41%-95.46%), respectively, due to indeterminate results. The rCIM-A was capable of discriminating between AHEs and true CPEs, but still failed to identify OXA-23-producing Proteus mirabilis isolates and remained only partially reliable for identifying IMI-like producers and a few MBL (2 NDM-1, 1 LMB-1, 1 TMB-1 and 1 IMP-13) producers. One chromosomally encoded AmpC variant, MIR-10, gave repeatedly positive results using all three tests and was thus considered a false positive.Conclusions: Specificity for AHEs greatly improved with the rCIM-A without altering the test performance for the other resistance mechanisms. It may replace the rCIM as a cheap, easy, rapid and accurate CPE detection test. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
25. Biochemical characterization of OXA-244, an emerging OXA-48 variant with reduced β-lactam hydrolytic activity.
- Author
-
Rima, Mariam, Emeraud, Cecile, Bonnin, Rémy A, Gonzalez, Camille, Dortet, Laurent, Iorga, Bogdan I, Oueslati, Saoussen, and Naas, Thierry
- Subjects
IMIPENEM ,CARBAPENEMS ,CARBAPENEMASE ,CLAVULANIC acid ,BETA lactam antibiotics ,TAZOBACTAM ,ESCHERICHIA coli ,PHYSICAL & theoretical chemistry ,RESEARCH ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,HYDROLASES ,COMPARATIVE studies ,RESEARCH funding ,MICROBIAL sensitivity tests ,ANTIBIOTICS ,PHARMACODYNAMICS - Abstract
Background: OXA-48-producing Enterobacterales have widely disseminated globally with an increasing number of variants identified. Among them, OXA-244 is increasingly reported, despite detection difficulties.Objectives: To determine the steady-state kinetic parameters of OXA-244.Methods: The blaOXA-244 gene was amplified, cloned into plasmids p-TOPO and pET41b+, and transformed into Escherichia coli TOP10 for MIC determination and E. coli BL21 DE3 for purification. Steady-state kinetic parameters and IC50s of clavulanic acid, tazobactam and NaCl were determined using purified OXA-244. Molecular modelling was also performed.Results: A reduction in MICs of temocillin and carbapenems was observed in E. coli expressing OXA-244 as compared with OXA-48. The kinetic parameters revealed a reduced carbapenemase activity of OXA-244 as compared with OXA-48, especially for imipenem, which was 10-fold lower. Similarly, catalytic efficiency (kcat/Km) was reduced by 4-fold and 20-fold for ampicillin and temocillin, respectively. Kinetic parameters for cephalosporins were, however, similar. Molecular modelling studies evidenced the key role of R214 in OXA-48, establishing salt bridges with D159 and with the carboxylate group of the R1 substituent of temocillin. These interactions are not possible with G214 in OXA-244, explaining the reduced affinity of temocillin for this enzyme. The R214G mutation in OXA-244 is also likely to induce changes in the active site's water network that would explain the decrease in the hydrolysis rate of carbapenems.Conclusions: Our data confirm that the R214G mutation (present in OXA-244) results in reduced carbapenem- and temocillin-hydrolysing activity, confirming the crucial role of residue 214 in the hydrolysis of these substrates by OXA-48-like β-lactamases. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
26. MDR bacterial isolates in environmental samples from Kinshasa, Democratic Republic of the Congo.
- Author
-
Oueslati, Saoussen, Raymond, Josette, Croue, Marianne, Carvahlo, Lara, Dortet, Laurent, Mbole, Anicet, and Naas, Thierry
- Subjects
- *
RESEARCH funding - Abstract
Two AMR isolates were found in the soapy water used for cleaning medical devices: one I Acinetobacter indicus i expressing I bla i SB NDM-1 sb and I bla i SB OXA-235 sb genes and one I Enterobacter chengduensis i expressing a I bla i SB CTX-M-15 sb gene. MDR Gram-negatives constitute a global public health concern, as they may cause severe, difficult-to-treat and often deadly infections, such as bloodstream infections and pneumonia. Carbapenem-resistant (CR) I Acinetobacter i spp. I Pseudomonas i spp. and Enterobacterales are among the most worrisome.[1] Even though these bacteria are increasingly described worldwide, epidemiological studies are very scarce from the African continent, except in Northern countries. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
27. Quantitative Assessment of SARS-CoV‑2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins.
- Author
-
Saadi, Justyna, Oueslati, Saoussen, Bellanger, Laurent, Gallais, Fabrice, Dortet, Laurent, Roque-Afonso, Anne-Marie, Junot, Christophe, Naas, Thierry, Fenaille, François, and Becher, François
- Published
- 2021
- Full Text
- View/download PDF
28. Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
- Author
-
Oueslati, Saoussen, Volland, Hervé, Cattoir, Vincent, Bernabeu, Sandrine, Girlich, Delphine, Dulac, Ducan, Plaisance, Marc, Laroche, Maxime, Dortet, Laurent, Simon, Stéphanie, and Naas, Thierry
- Subjects
- *
IMMUNOASSAY , *MEDICAL microbiology , *ENTEROCOCCUS , *AGAR plates , *BACTERIAL growth , *DETECTION limit , *BACTERIAL proteins , *VANCOMYCIN resistance , *RESEARCH , *RESEARCH methodology , *VANCOMYCIN , *MEDICAL cooperation , *EVALUATION research , *GRAM-positive bacterial infections , *COMPARATIVE studies , *ENZYMES - Abstract
Background: VRE are nosocomial pathogens with an increasing incidence in recent decades. Rapid detection is crucial to reduce their spread and prevent infections and outbreaks.Objectives: To evaluate a lateral flow immunoassay (LFIA) (called NG-Test VanA) for the rapid and reliable detection of VanA-producing VRE (VanA-VRE) from colonies and broth.Methods: NG-Test VanA was validated on 135 well-characterized enterococcal isolates grown on Mueller-Hinton (MH) agar (including 40 VanA-VRE). Different agar plates and culture broths widely used in routine laboratories for culture of enterococci were tested.Results: All 40 VanA-VRE clinical isolates were correctly detected in less than 15 min irrespective of the species expressing the VanA ligase and the medium used for bacterial growth. No cross-reaction was observed with any other clinically relevant ligases (VanB, C1, C2, D, E, G, L, M and N). Overall, the sensitivity and specificity of the assay were 100% for VanA-VRE grown on MH agar plates. NG-Test VanA accurately detects VanA-VRE irrespective of the culture medium (agar and broth). Band intensity was increased when using bacteria grown on vancomycin-containing culture media or on MH close to the vancomycin disc as a consequence of VanA induction. The limit of detection of the assay was 6.3 × 106 cfu per test with bacteria grown on MH plates and 4.9 × 105 cfu per test with bacteria grown on ChromID® VRE plates.Conclusions: NG-Test VanA is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratory for the confirmation of VanA-VRE. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
29. Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity.
- Author
-
Oueslati, Saoussen, Iorga, Bogdan I, Tlili, Linda, Exilie, Cynthia, Zavala, Agustin, Dortet, Laurent, Jousset, Agnès B, Bernabeu, Sandrine, Bonnin, Rémy A, and Naas, Thierry
- Subjects
- *
CEFTAZIDIME , *BETA lactamases , *MOLECULAR cloning , *GENETIC vectors , *MOLECULAR docking , *ESCHERICHIA coli - Abstract
Background: KPC-like carbapenemases have spread worldwide with more than 30 variants identified that differ by single or double amino-acid substitutions.Objectives: To describe the steady-state kinetic parameters of KPC-28, which differs from KPC-2 by a H274Y substitution and the deletion of two amino acids (Δ242-GT-243).Methods: The blaKPC-2, blaKPC-3, blaKPC-14 and blaKPC-28 genes were cloned into a pTOPO vector for susceptibility testing or into pET41b for overexpression, purification and subsequent kinetic parameter (Km, kcat) determination. Molecular docking experiments were performed to explore the role of the amino-acid changes in the carbapenemase activity.Results: Susceptibility testing revealed that Escherichia coli producing KPC-28 displayed MICs that were lower for carbapenems and higher for ceftazidime and ceftazidime/avibactam as compared with KPC-2. The catalytic efficiencies of KPC-28 and KPC-14 for imipenem were 700-fold and 200-fold lower, respectively, than those of KPC-2, suggesting that Δ242-GT-243 in KPC-28 and KPC-14 is responsible for reduced carbapenem hydrolysis. Similarly, the H274Y substitution resulted in KPC-28 in a 50-fold increase in ceftazidime hydrolysis that was strongly reversed by clavulanate.Conclusions: We have shown that KPC-28 lacks carbapenemase activity, has increased ceftazidime hydrolytic activity and is strongly inhibited by clavulanate. KPC-28-producing E. coli isolates display an avibactam-resistant ESBL profile, which may be wrongly identified by molecular and immunochromatographic assays as the presence of a carbapenemase. Accordingly, confirmation of carbapenem hydrolysis will be mandatory with assays based solely on blaKPC gene or gene product detection. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
30. A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae.
- Author
-
Boutal, Hervé, Vogel, Anaïs, Bernabeu, Sandrine, Devilliers, Karine, Creton, Elodie, Cotellon, Garence, Plaisance, Marc, Oueslati, Saoussen, Dortet, Laurent, Jousset, Agnès, Simon, Stéphanie, Naas, Thierry, and Volland, Hervé
- Subjects
CULTURE media (Biology) ,DIAGNOSTIC errors ,DRUG resistance ,ENTEROBACTERIACEAE ,IMMUNOASSAY ,LONGITUDINAL method ,MICROBIAL sensitivity tests ,RETROSPECTIVE studies ,CARBAPENEMS - Abstract
Objectives: The global spread of carbapenemase-producing Enterobacteriaceae represents a substantial challenge in clinical practice and rapid and reliable detection of these organisms is essential. The aim of this study was to develop and validate a lateral flow immunoassay (Carba5) for the detection of the five main carbapenemases (KPC-, NDM-, VIM- and IMP-type and OXA-48-like).Methods: Carba5 was retrospectively and prospectively evaluated using 296 enterobacterial isolates from agar culture. An isolated colony was suspended in extraction buffer and then loaded on the manufactured Carba5.Results: All 185 isolates expressing a carbapenemase related to one of the Carba5 targets were correctly and unambiguously detected in <15 min. All other isolates gave negative results except those producing OXA-163 and OXA-405, which are considered low-activity carbapenemases. No cross-reaction was observed with non-targeted carbapenemases, ESBLs, AmpCs or oxacillinases (OXA-1, -2, -9 and -10). Overall, this assay reached 100% sensitivity and 95.3% (retrospectively) to 100% (prospectively) specificity.Conclusions: Carba5 is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratory for confirmation of the five main carbapenemases encountered in Enterobacteriaceae. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
31. A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae.
- Author
-
Boutai, Hervé, Vogel, Anaïs, Bernabeu, Sandrine, Devilliers, Karine, Creton, Elodie, Cotellon, Garence, Plaisance, Marc, Oueslati, Saoussen, Dortet, Laurent, Jousset, Agnès, Simon, Stephanie, Naas, Thierry, and Volland, Herve
- Subjects
IMMUNOASSAY ,ENTEROBACTERIACEAE ,CARBAPENEMASE ,BACTERIAL cultures ,BUFFER solutions - Abstract
Objectives: The global spread of carbapenemase-producing Enterobacteriaceae represents a substantial challenge in clinical practice and rapid and reliable detection of these organisms is essential. The aim of this study was to develop and validate a lateral flow immunoassay (Carba5) for the detection of the five main carbapene- mases (KPC-, NDM-, VIM- and IMP-type and OXA-48-like). Methods: Carba5 was retrospectively and prospectively evaluated using 296 enterobacterial isolates from agar culture. An isolated colony was suspended in extraction buffer and then loaded on the manufactured Carba5. Results: All 185 isolates expressing a carbapenemase related to one of the Carba5 targets were correctly and unambiguously detected in <15 min. All other isolates gave negative results except those producing OXA-163 and OXA-405, which are considered low-activity carbapenemases. No cross-reaction was observed with non- targeted carbapenemases, ESBLs, AmpCs or oxacillinases (OXA-1, -2, -9 and -10). Overall, this assay reached 100% sensitivity and 95.3% (retrospectively) to 100% (prospectively) specificity. Conclusions: Carba5 is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratoryfor confirmation of the five main carbapenemases encountered in Enterobacteriaceae. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
32. Beta-lactamase database (BLDB) – structure and function.
- Author
-
Naas, Thierry, Oueslati, Saoussen, Bonnin, Rémy A., Dabos, Maria Laura, Zavala, Agustin, Dortet, Laurent, Retailleau, Pascal, and Iorga, Bogdan I.
- Subjects
- *
BETA lactamases , *ANTIBIOTICS assay , *GRAM-negative bacteria , *SEQUENCE alignment , *DATABASES , *PHYSIOLOGY - Abstract
Beta-Lactamase Database (BLDB) is a comprehensive, manually curated public resource providing up-to-date structural and functional information focused on this superfamily of enzymes with a great impact on antibiotic resistance. All the enzymes reported and characterised in the literature are presented according to the class (A, B, C and D), family and subfamily to which they belong. All three-dimensional structures of β-lactamases present in the Protein Data Bank are also shown. The characterisation of representative mutants and hydrolytic profiles (kinetics) completes the picture and altogether these four elements constitute the essential foundation for a better understanding of the structure-function relationship within this enzymes family. BLDB can be queried using different protein- and nucleotide-based BLAST searches, which represents a key feature of particular importance in the context of the surveillance of the evolution of the antibiotic resistance. BLDB is available online athttp://bldb.euwithout any registration and supports all modern browsers. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
33. To Be or Not to Be an OXA-48 Carbapenemase.
- Author
-
Dabos, Laura, Oueslati, Saoussen, Bernabeu, Sandrine, Bonnin, Rémy A., Dortet, Laurent, and Naas, Thierry
- Subjects
CARBAPENEMASE ,IMIPENEM ,ACTIVITY coefficients ,CARBAPENEMS ,CEPHALOSPORINS ,ENZYMES - Abstract
Since the first description of OXA-48, more than forty variants have been recovered from Enterobacterales isolates. Whereas some OXA-48-related enzymes have been reported as conferring similar resistance patterns, namely, the hydrolysis of carbapenems and penicillins with very weak or almost no activity against expanded-spectrum cephalosporins, some have reduced carbapenem and temocillin hydrolysis, and others hydrolyze expanded-spectrum cephalosporins and carbapenems only marginally. With such drastic differences in the hydrolytic profile, especially of carbapenems, it becomes urgent to establish hydrolytic cutoffs in order to determine when an OXA-48-like enzyme may be considered as a carbapenemase or not. With this aim, the coefficient of activity for imipenem (k
cat /Km ) was determined for a total of 30 enzymes, including OXA-48, OXA-48-like natural variants, and OXA-48 synthetic mutants. In addition, six different methods for the detection of carbapenemase-producers were performed. The coefficients of activity for imipenem for all the different enzymes went from 550 mM−1 ·s−1 to 0.02 mM−1 ·s−1 . In order to match the coefficient of activity results with the biochemical confirmatory tests, we suggest the value of 0.27 mM−1 ·s−1 as the cutoff above which an OXA-48 variant may be considered a carbapenem-hydrolyzing enzyme. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
34. Comparison of Three Expanded-Spectrum Cephalosporin Hydrolysis Assays and the NG-Test CTX-M Multi Assay That Detects All CTX-M-Like Enzymes.
- Author
-
Gonzalez, Camille, Moguet, Christian, Chalin, Arnaud, Oueslati, Saoussen, Dortet, Laurent, Simon, Stéphanie, Volland, Hervé, and Naas, Thierry
- Subjects
HYDROLYSIS ,ENZYMES ,ANTIMICROBIAL stewardship ,INFECTION control ,IMMUNOASSAY - Abstract
Rapid detection of expanded-spectrum cephalosporins (ESC) hydrolysing enzymes is crucial to implement infection control measures and antibiotic stewardship. Here, we have evaluated three biochemical ESC hydrolysis assays (ESBL NDP test, β-LACTA™ test, LFIA-CTX assay) and the NG-Test
® CTX-M MULTI that detects CTX-M enzymes, on 93 well-characterized Gram-negative isolates, including 60 Enterobacterales, 21 Pseudomonas spp. and 12 Acinetobacter spp. The performances were good for all three hydrolysis assays, with the LFIA-CTX being slightly more sensitive and specific on the tested panel of isolates especially with Enterobacterales, without ambiguous results. This study showed that LFIA-CTX may be used for the detection of ESC hydrolysis as a competitive alternative to already available assays (β-LACTA™ test and ESBL NDP test) without any specific equipment and reduced hands-on-time. The lateral flow immunoassay NG-Test® CTX-M MULTI has proven to be a useful, easy, rapid, and reliable confirmatory test in Enterobacterales for detection of CTX-M-type ESBLs, which account for most of the resistance mechanisms leading to ESC resistance in Enterobacterales, but it misses rare ESC hydrolysing β-lactamases (AmpC, minor ESBLs, and carbapenemases). Combining it with the LFIA-CTX assay would yield an assay detecting the most frequently-encountered ESBLs (CTX-M-like β-lactamases) together with ESC hydrolysis. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
35. Rapid Detection of VanA/B-Producing Vancomycin-Resistant Enterococci Using Lateral Flow Immunoassay.
- Author
-
Oueslati, Saoussen, Gonzalez, Camille, Volland, Hervé, Cattoir, Vincent, Bernabeu, Sandrine, Girlich, Delphine, Dulac, Duncan, Plaisance, Marc, Boutigny, Laure, Dortet, Laurent, Simon, Stéphanie, and Naas, Thierry
- Subjects
- *
MEDICAL microbiology , *IMMUNOASSAY , *VANCOMYCIN resistance , *SENSITIVITY & specificity (Statistics) , *ENTEROCOCCUS , *PATHOLOGICAL laboratories , *BACTERIAL cells - Abstract
Vancomycin-resistant enterococci (VREs) have become one of the most important nosocomial pathogens worldwide, associated with increased treatment costs, prolonged hospital stays and high mortality. Rapid detection is crucial to reduce their spread and prevent infections and outbreaks. The lateral flow immunoassay NG-Test VanB (NG Biotech) was evaluated for the rapid detection of VanB-producing vancomycin-resistant enterococci (VanB-VREs) using 104 well-characterized enterococcal isolates. The sensitivity and specificity were both 100% when bacterial cells were grown in the presence of vancomycin used as a VanB inducer. The NG-Test VanB is an efficient, rapid and easy to implement assay in clinical microbiology laboratories for the confirmation of VanB-VREs from colonies. Together with the NG-Test VanA, they could replace the already existing tests available for the confirmation of acquired vancomycin resistance in enterococci, especially from selective media or from antibiograms, with 100% sensitivity and specificity. Rapid detection in less than 15 min will result in more efficient management of carriers and infected patients. In addition, these tests may be used for positive blood cultures, given a 3.5 h sub-culturing step on Chocolate agar PolyViteX in the presence of a 5-µg vancomycin disk, which is routinely performed in many clinical microbiology laboratories for every positive blood culture for subsequent MALDI-TOF identification of the growing bacteria. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
36. A Lateral Flow Immunoassay for the Rapid Identification of CTX-M-Producing Enterobacterales from Culture Plates and Positive Blood Cultures.
- Author
-
Bernabeu, Sandrine, Ratnam, Kayaththiry Caroline, Boutal, Hervé, Gonzalez, Camille, Vogel, Anaïs, Devilliers, Karine, Plaisance, Marc, Oueslati, Saoussen, Malhotra-Kumar, Surbhi, Dortet, Laurent, Fortineau, Nicolas, Simon, Stéphanie, Volland, Hervé, and Naas, Thierry
- Subjects
IMMUNOASSAY ,MEDICAL microbiology ,AGAR plates ,BLOOD ,PATHOLOGICAL laboratories - Abstract
We have developed a lateral flow immunoassay (LFIA), named NG-Test CTX-M MULTI (NG-Test), to detect group 1, 2, 8, 9, 25 CTX-M producers from agar plates and from positive blood cultures in less than 15 min. The NG-Test was validated retrospectively on 113 well-characterized enterobacterial isolates, prospectively on 102 consecutively isolated ESBL-producers from the Bicêtre hospital and on 100 consecutive blood cultures positive with a gram-negative bacilli (GNB). The NG-Test was able to detect all CTX-M producers grown on the different agar plates used in clinical microbiology laboratories. No false positive nor negative results were observed. Among the 102 consecutive ESBL isolates, three hyper mucous isolates showed an incorrect migration leading to invalid results (no control band). Using an adapted protocol, the results could be validated. The NG-Test detected 99/102 ESBLs as being CTX-Ms. Three SHV producers were not detected. Among the 100 positive blood cultures with GNB tested 10/11 ESBL-producers were detected (8 CTX-M-15, 2 CTX-M-27). One SHV-2-producing-E. cloacae was missed. The NG-Test CTX-M MULTI showed 100% sensitivity and specificity with isolates cultured on agar plates and was able to detect 98% of the ESBL-producers identified in our clinical setting either from colonies or from positive blood cultures. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity.
- Author
-
Oueslati, Saoussen, Retailleau, Pascal, Marchini, Ludovic, Dortet, Laurent, Bonnin, Rémy A., Iorga, Bogdan I., and Naas, Thierry
- Subjects
WATER distribution ,MOLECULAR dynamics ,STRUCTURAL design ,WELL water ,DRUG resistance in bacteria ,BINDING energy ,BETA lactamases - Abstract
OXA-48-producing Enterobacterales have now widely disseminated globally. A sign of their extensive spread is the identification of an increasing number of OXA-48 variants. Among them, three are particularly interesting, OXA-163, OXA-247 and OXA-405, since they have lost carbapenem activities and gained expanded-spectrum cephalosporin hydrolytic activity subsequent to a four amino-acid (AA) deletion in the β5–β6 loop. We investigated the mechanisms responsible for substrate specificity of OXA-405. Kinetic parameters confirmed that OXA-405 has a hydrolytic profile compatible with an ESBL (hydrolysis of expanded spectrum cephalosporins and susceptibility to class A inhibitors). Molecular modeling techniques and 3D structure determination show that the overall dimeric structure of OXA-405 is very similar to that of OXA-48, except for the β5–β6 loop, which is shorter for OXA-405, suggesting that the length of the β5–β6 loop is critical for substrate specificity. Covalent docking with selected substrates and molecular dynamics simulations evidenced the structural changes induced by substrate binding, as well as the distribution of water molecules in the active site and their role in substrate hydrolysis. All this data may represent the structural basis for the design of new and efficient class D inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
38. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia.
- Author
-
Jaidane, Nadia, Naas, Thierry, Oueslati, Saoussen, Bernabeu, Sandrine, Boujaafar, Noureddine, Bouallegue, Olfa, and Bonnin, Rémy A.
- Subjects
- *
ACINETOBACTER baumannii , *BETA lactamases , *ELECTROPORATION , *ELECTRON-transfer catalysis , *ACINETOBACTER , *POLYMERASE chain reaction , *MOLECULAR cloning - Abstract
Highlights • Genomic analysis of NDM-producing Acinetobacter baumannii from Tunisia. • The clonal relationship revealed that these isolates were highly related. • This clone corresponds to a clone recovered from France 5 years ago. • Conjugation and electroporation experiments suggested that the bla NDM-1 gene is likely to be chromosomally located. ABSTRACT Background New Delhi metallo-β-lactamase (NDM)-producing Acinetobacter baumannii have been described in several countries worldwide, and studies have suggested that Acinetobacter spp. could play the role of intermediate progenitor of the bla NDM-1 gene between environmental progenitor and Enterobacteriaceae. Materials and methods In total, 246 carbapenem-resistant A. baumannii isolates from a teaching hospital in Sousse, Tunisia were investigated between 1st June 2013 and 31st December 2015 to detect metallo-ß-lactamase (MBL) production. Polymerase chain reaction (PCR), antibiotic susceptibility testing, and genetic and whole-genome sequencing tools were used to study the underlying carbapenem resistance mechanisms. Results PCR screening of the 246 carbapenem-resistant A. baumannii isolates revealed that 242 of 246 isolates harboured carbapenemase genes (seven of 246 positive for bla NDM-1 , four of 246 positive for bla NDM-1 and bla OXA-23 , 231 positive for bla OXA-23). Conjugation and electroporation experiments suggested that the bla NDM-1 gene is likely to be chromosomally located. All the NDM-1-producing A. baumannii isolates were clonally related, and belonged to ST85 according to the Pasteur Institute's multi-locus sequence typing scheme. Analysis of the immediate genetic environment of the bla NDM-1 gene revealed that the gene was located within a truncated isoform of Tn 125 transposon (ΔTn 125). The bla OXA-23 gene was located within transposon Tn 2008. Conclusion This study showed the dissemination of a single clone of NDM-1-producing A. baumannii in a Tunisian hospital. Countries in north Africa may constitute a significant reservoir for NDM-1-producing A. baumannii. The spread of the bla NDM-1 gene in A. baumannii was linked to clonal spread in this study. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.